Applicability criteria for the model
Adult (≥18 years).
Histologically diagnosed, resistant or progressing metastatic colorectal cancer.
At least one oxaliplatin-based first-line chemotherapy or tumor relapse in the first 6 months following adjuvant treatment (“rapid progressors”).
The patient is about to start a chemotherapy regimen based on irinotecan and aflibercept.
Ok, go ahead
Por favor, espere